Journal

Gut
ISSN: 1468-3288
Titre abrégé: Gut
Pays: England
ID NLM: 2985108R

Informations de publication

Date de publication:
07 2019
Historique:
received: 21 09 2018
revised: 14 01 2019
accepted: 15 01 2019
pubmed: 23 3 2019
medline: 28 7 2019
entrez: 23 3 2019
Statut: ppublish

Résumé

We aimed at the identification of genetic alterations that may functionally substitute for Large cohorts of HCA (n=185) and HCC (n=468) were classified using immunohistochemistry. The mutational status of the A The

Identifiants

pubmed: 30901310
pii: gutjnl-2018-317632
doi: 10.1136/gutjnl-2018-317632
doi:

Substances chimiques

CTNNB1 protein, human 0
Intercellular Signaling Peptides and Proteins 0
Rspo2 protein, human 0
beta Catenin 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Pagination

1287-1296

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Thomas Longerich (T)

Institute of Pathology, UniversitatsKlinikum Heidelberg, Heidelberg, Germany.
Liver Cancer Center Heidelberg, UniversitatsKlinikum Heidelberg, Heidelberg, Germany.

Volker Endris (V)

Institute of Pathology, UniversitatsKlinikum Heidelberg, Heidelberg, Germany.

Olaf Neumann (O)

Institute of Pathology, UniversitatsKlinikum Heidelberg, Heidelberg, Germany.

Eugen Rempel (E)

Institute of Pathology, UniversitatsKlinikum Heidelberg, Heidelberg, Germany.

Martina Kirchner (M)

Institute of Pathology, UniversitatsKlinikum Heidelberg, Heidelberg, Germany.

Zahra Abadi (Z)

Institute of Pathology, UniversitatsKlinikum Heidelberg, Heidelberg, Germany.

Sebastian Uhrig (S)

Faculty of Bioscience, Ruprecht Karls University Heidelberg, Heidelberg, Germany.
Division of Applied Bioinformatics, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Mark Kriegsmann (M)

Institute of Pathology, UniversitatsKlinikum Heidelberg, Heidelberg, Germany.

Karl Heinz Weiss (KH)

Liver Cancer Center Heidelberg, UniversitatsKlinikum Heidelberg, Heidelberg, Germany.
Department of Internal Medicine IV, UniversitatsKlinikum Heidelberg, Heidelberg, Germany.

Kai Breuhahn (K)

Institute of Pathology, UniversitatsKlinikum Heidelberg, Heidelberg, Germany.

Arianeb Mehrabi (A)

Liver Cancer Center Heidelberg, UniversitatsKlinikum Heidelberg, Heidelberg, Germany.
Department of General, Visceral and Transplantation Surgery, UniversitatsKlinikum Heidelberg, Heidelberg, Germany.

Tim Frederik Weber (TF)

Liver Cancer Center Heidelberg, UniversitatsKlinikum Heidelberg, Heidelberg, Germany.
Diagnostic and Interventional Radiology, University Hospital Heidelberg, Heidelberg, Germany.

Ludwig Wilkens (L)

Institute for Pathology, KRH, Nordstadt Krankenhaus, Hannover, Germany.
Institute for Human Genetics, Medical School Hannover, Hannover, Germany.

Beate K Straub (BK)

Institute of Pathology, Johannes Gutenberg Universitat Universitatsmedizin, Mainz, Germany.

Andreas Rosenwald (A)

Institute of Pathology, University of Wuerzburg and Comprehensive Cancer Center Mainfranken, Würzburg, Germany.

Falko Schulze (F)

Senckenberg Institute of Pathology, Klinikum der Johann Wolfgang Goethe-Universitat Frankfurt, Frankfurt am Main, Germany.

Benedikt Brors (B)

Division of Applied Bioinformatics, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Stefan Froehling (S)

Division of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany.
German Cancer Consortium (DKTK), Heidelberg, Germany.

Rossella Pellegrino (R)

Institute of Pathology, UniversitatsKlinikum Heidelberg, Heidelberg, Germany.

Jan Budczies (J)

Institute of Pathology, UniversitatsKlinikum Heidelberg, Heidelberg, Germany.

Peter Schirmacher (P)

Institute of Pathology, UniversitatsKlinikum Heidelberg, Heidelberg, Germany.
Liver Cancer Center Heidelberg, UniversitatsKlinikum Heidelberg, Heidelberg, Germany.

Albrecht Stenzinger (A)

Institute of Pathology, UniversitatsKlinikum Heidelberg, Heidelberg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH